|
|
Blood, 1 February 2004, Vol. 103, No. 3, pp. 761-766.
Prepublished online as a Blood First Edition Paper on October 2, 2003; DOI 10.1182/blood-2003-06-1974.

Submitted June 18, 2003
Accepted September 22, 2003
Bifunctional role for VEGF-induced heme oxygenase-1 in vivo: induction of angiogenesis and inhibition of leukocytic infiltration
Benedetta Bussolati, Asif Ahmed*, Helen Pemberton, Robert Clive Landis, Francesco Di Carlo, Dorian O Haskard, and Justin C Mason
Department of Biology and Clinical Science, University of Torino, Turin, Italy
Department of Reproductive and Vascular Biology, University of Birmingham, Birmingham, United Kingdom
Cardiovascular Medicine Unit, The Eric Bywaters Center, Imperial College London, London, United Kingdom
* Corresponding author; email: a.s.ahmed{at}bham.ac.uk.
Heme-oxygenases (HO) catalyse the conversion of heme into carbon monoxide and biliverdin. HO-1 is induced during hypoxia, ischemia/reperfusion and inflammation, providing cytoprotection and inhibiting leukocyte migration to inflammatory sites. Although in vitro studies have suggested an additional role for HO-1 in angiogenesis, the relevance of this in vivo remains unknown. We investigated the involvement of HO-1 in angiogenesis in vitro and in vivo. VEGF induced prolonged HO-1 expression and activity in human endothelial cells and HO-1 inhibition abrogated VEGF-driven angiogenesis. Two murine models of angiogenesis were used: (1) angiogenesis initiated by addition of VEGF to Matrigel and (2) an LPS-induced model of inflammatory angiogenesis in which angiogenesis is secondary to leukocyte invasion. Pharmacological inhibition of HO-1 induced marked leukocytic infiltration which enhanced VEGF-induced angiogenesis. However, in the presence of an anti-CD18 mAb to block leukocyte migration, VEGF-induced angiogenesis was significantly inhibited by HO-1 antagonists. Furthermore, in the LPS-induced model of inflammatory angiogenesis, induction of HO-1 with cobalt protoporphyrin significantly inhibited leukocyte invasion into LPS-conditioned Matrigel and thus prevented the subsequent angiogenesis. We therefore propose that during chronic inflammation HO-1 has two roles, first an anti-inflammatory action inhibiting leukocyte infiltration and second promotion of VEGF-driven non-inflammatory angiogenesis which facilitates tissue repair.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
Related Article in Blood Online:
-
VEGF: is it just an inducer of heme oxygenase-1 expression?
- Miguel P. Soares
Blood 2004 103: 751.
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
L. Bellner, L. Martinelli, A. Halilovic, K. Patil, N. Puri, M. W. Dunn, R. F. Regan, and M. L. Schwartzman
Heme Oxygenase-2 Deletion Causes Endothelial Cell Activation Marked by Oxidative Stress, Inflammation, and Angiogenesis
J. Pharmacol. Exp. Ther.,
December 1, 2009;
331(3):
925 - 932.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Gueron, A. De Siervi, M. Ferrando, M. Salierno, P. De Luca, B. Elguero, R. Meiss, N. Navone, and E. S. Vazquez
Critical Role of Endogenous Heme Oxygenase 1 as a Tuner of the Invasive Potential of Prostate Cancer Cells
Mol. Cancer Res.,
November 1, 2009;
7(11):
1745 - 1755.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. J. Wu, R. G. Midwinter, C. Cassano, K. Beck, Y. Wang, D. Changsiri, J. R. Gamble, and R. Stocker
Heme Oxygenase-1 Increases Endothelial Progenitor Cells
Arterioscler Thromb Vasc Biol,
October 1, 2009;
29(10):
1537 - 1542.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kitazume, R. Oka, K. Ogawa, S. Futakawa, Y. Hagiwara, H. Takikawa, M. Kato, A. Kasahara, E. Miyoshi, N. Taniguchi, et al.
Molecular insights into {beta}-galactoside {alpha}2,6-sialyltransferase secretion in vivo
Glycobiology,
May 1, 2009;
19(5):
479 - 487.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C.-F. Chen and C.-H. Cheng
Regulation of Cellular Metabolism and Cytokines by the Medicinal Herb Feverfew in the Human Monocytic THP-1 Cells
Evid. Based Complement. Altern. Med.,
March 1, 2009;
6(1):
91 - 98.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. R. Kinderlerer, I. Pombo Gregoire, S. S. Hamdulay, F. Ali, R. Steinberg, G. Silva, N. Ali, B. Wang, D. O. Haskard, M. P. Soares, et al.
Heme oxygenase-1 expression enhances vascular endothelial resistance to complement-mediated injury through induction of decay-accelerating factor: a role for increased bilirubin and ferritin
Blood,
February 12, 2009;
113(7):
1598 - 1607.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Bilban, P. Haslinger, J. Prast, F. Klinglmuller, T. Woelfel, S. Haider, A. Sachs, L. E. Otterbein, G. Desoye, U. Hiden, et al.
Identification of Novel Trophoblast Invasion-Related Genes: Heme Oxygenase-1 Controls Motility via Peroxisome Proliferator-Activated Receptor {gamma}
Endocrinology,
February 1, 2009;
150(2):
1000 - 1013.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Williams, T. Rangasamy, S. M. Bauer, S. Killedar, M. Karp, T. W. Kensler, M. Yamamoto, P. Breysse, S. Biswal, and S. N. Georas
Disruption of the Transcription Factor Nrf2 Promotes Pro-Oxidative Dendritic Cells That Stimulate Th2-Like Immunoresponsiveness upon Activation by Ambient Particulate Matter
J. Immunol.,
October 1, 2008;
181(7):
4545 - 4559.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. K. Idriss, A. D. Blann, and G. Y.H. Lip
Hemoxygenase-1 in Cardiovascular Disease
J. Am. Coll. Cardiol.,
September 16, 2008;
52(12):
971 - 978.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Tongers, J.-M. Knapp, M. Korf, T. Kempf, A. Limbourg, F. P. Limbourg, Z. Li, D. Fraccarollo, J. Bauersachs, X. Han, et al.
Haeme oxygenase promotes progenitor cell mobilization, neovascularization, and functional recovery after critical hindlimb ischaemia in mice
Cardiovasc Res,
May 1, 2008;
78(2):
294 - 300.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. M. Birdsey, N. H. Dryden, V. Amsellem, F. Gebhardt, K. Sahnan, D. O. Haskard, E. Dejana, J. C. Mason, and A. M. Randi
Transcription factor Erg regulates angiogenesis and endothelial apoptosis through VE-cadherin
Blood,
April 1, 2008;
111(7):
3498 - 3506.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Dulak, J. Deshane, A. Jozkowicz, and A. Agarwal
Heme Oxygenase-1 and Carbon Monoxide in Vascular Pathobiology: Focus on Angiogenesis
Circulation,
January 15, 2008;
117(2):
231 - 241.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Steinberg, O. A. Harari, E. A. Lidington, J. J. Boyle, M. Nohadani, A. M. Samarel, M. Ohba, D. O. Haskard, and J. C. Mason
A Protein Kinase C{epsilon}-Anti-apoptotic Kinase Signaling Complex Protects Human Vascular Endothelial Cells against Apoptosis through Induction of Bcl-2
J. Biol. Chem.,
November 2, 2007;
282(44):
32288 - 32297.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Datta, O. Dormond, A. Basu, D. M. Briscoe, and S. Pal
Heme oxygenase-1 modulates the expression of the anti-angiogenic chemokine CXCL-10 in renal tubular epithelial cells
Am J Physiol Renal Physiol,
October 1, 2007;
293(4):
F1222 - F1230.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Weigel, I. Kajgana, H. Bergmeister, G. Riedl, H.-D. Glogar, M. Gyongyosi, S. Blasnig, G. Heinze, and W. Mohl
Beck and back: A paradigm change in coronary sinus interventions--pulsatile stretch on intact coronary venous endothelium
J. Thorac. Cardiovasc. Surg.,
June 1, 2007;
133(6):
1581 - 1587.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Kronke, A. Kadl, E. Ikonomu, S. Bluml, A. Furnkranz, I. J. Sarembock, V. N. Bochkov, M. Exner, B. R. Binder, and N. Leitinger
Expression of Heme Oxygenase-1 in Human Vascular Cells Is Regulated by Peroxisome Proliferator-Activated Receptors
Arterioscler Thromb Vasc Biol,
June 1, 2007;
27(6):
1276 - 1282.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Larghero, R. Vene, S. Minghelli, G. Travaini, M. Morini, N. Ferrari, U. Pfeffer, D. M. Noonan, A. Albini, and R. Benelli
Biological assays and genomic analysis reveal lipoic acid modulation of endothelial cell behavior and gene expression
Carcinogenesis,
May 1, 2007;
28(5):
1008 - 1020.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Deshane, S. Chen, S. Caballero, A. Grochot-Przeczek, H. Was, S. Li Calzi, R. Lach, T. D. Hock, B. Chen, N. Hill-Kapturczak, et al.
Stromal cell-derived factor 1 promotes angiogenesis via a heme oxygenase 1-dependent mechanism
J. Exp. Med.,
March 19, 2007;
204(3):
605 - 618.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. D. Hock, K. Liby, M. M. Wright, S. McConnell, M. Schorpp-Kistner, T. M. Ryan, and A. Agarwal
JunB and JunD Regulate Human Heme Oxygenase-1 Gene Expression in Renal Epithelial Cells
J. Biol. Chem.,
March 2, 2007;
282(9):
6875 - 6886.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Milkiewicz, O. Hudlicka, R. Shiner, S. Egginton, and M. D. Brown
Vascular endothelial growth factor mRNA and protein do not change in parallel during non-inflammatory skeletal muscle ischaemia in rat
J. Physiol.,
December 1, 2006;
577(2):
671 - 678.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-T. Tien, S. E. Girardin, B. Regnault, L. Le Bourhis, M.-A. Dillies, J.-Y. Coppee, R. Bourdet-Sicard, P. J. Sansonetti, and T. Pedron
Anti-Inflammatory Effect of Lactobacillus casei on Shigella-Infected Human Intestinal Epithelial Cells
J. Immunol.,
January 15, 2006;
176(2):
1228 - 1237.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. H. Bach
Heme oxygenase-1: a therapeutic amplification funnel
FASEB J,
August 1, 2005;
19(10):
1216 - 1219.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P.-C. Lee, I-C. Ho, and T.-C. Lee
Oxidative Stress Mediates Sodium Arsenite-Induced Expression of Heme Oxygenase-1, Monocyte Chemoattractant Protein-1, and Interleukin-6 in Vascular Smooth Muscle Cells
Toxicol. Sci.,
May 1, 2005;
85(1):
541 - 550.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-O. Pae, G.-S. Oh, B.-M. Choi, Y.-M. Kim, and H.-T. Chung
A Molecular Cascade Showing Nitric Oxide-Heme Oxygenase-1-Vascular Endothelial Growth Factor-Interleukin-8 Sequence in Human Endothelial Cells
Endocrinology,
May 1, 2005;
146(5):
2229 - 2238.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Frantz, K. A. Vincent, O. Feron, and R. A. Kelly
Innate Immunity and Angiogenesis
Circ. Res.,
January 7, 2005;
96(1):
15 - 26.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Zhao, K. Egashira, K.-i. Hiasa, M. Ishibashi, S. Inoue, K. Ohtani, C. Tan, M. Shibuya, A. Takeshita, and K. Sunagawa
Essential Role of Vascular Endothelial Growth Factor and Flt-1 Signals in Neointimal Formation After Periadventitial Injury
Arterioscler Thromb Vasc Biol,
December 1, 2004;
24(12):
2284 - 2289.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Shimizu, Y. Masuda, T. Mori, H. Kitamura, M. Ishizaki, Y. Sugisaki, and Y. Fukuda
Vascular Endothelial Growth Factor165 Resolves Glomerular Inflammation and Accelerates Glomerular Capillary Repair in Rat Anti-Glomerular Basement Membrane Glomerulonephritis
J. Am. Soc. Nephrol.,
October 1, 2004;
15(10):
2655 - 2665.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Blazquez, L. Gonzalez-Feria, L. Alvarez, A. Haro, M. L. Casanova, and M. Guzman
Cannabinoids Inhibit the Vascular Endothelial Growth Factor Pathway in Gliomas
Cancer Res.,
August 15, 2004;
64(16):
5617 - 5623.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|